COMMUTE

The COMMUTE project is designed to study the risk of dementia and neurodegeneration after infection with COVID-19. The study will analyse the underlying mechanisms that could link this infection to an increased risk of developing neurodegenerative diseases.

This project is financed by the European Union and involves 11 partners from different European countries. In the COMMUTE framework, computational and biological research techniques will be combined, using artificial intelligence, to analyse patient data and determine whether the infection with COVID-19 increases the risk of neurodegenerative diseases.

The BBRC has a significant role in the work package 4 “Mechanisms, Testing, and Validation” of the COMMUTE project, for experimental validation of biomarkers and action mechanisms, providing our experience in neuroimaging, biomarkers, cell models, and organoids, and also, providing data from our unique cohort, in order to better understand the connection between COVID-19 and neurodegenerative diseases.

This research is critical to better understand the long-term effects of COVID-19 and to develop preventive and therapeutic strategies to reduce the risk of dementia in the future. 

GA: 101136957
Principal Investigator: Arcadi Navarro